Division of Endocrinology

Project	Investigator	All Organizations	Start date	End date
Determination and optimization of the mechanism of action for efficacy of Gleevec in the type I diabetes NOD mouse model	Jeffrey Bluestone, PhD	Division of Endocrinology	7/28/08	7/27/09
DDT and PBDE Exposure, Puberty Onset, and Neurodevelopment in 9-Year-Old Children	Robert Lustig, MD	Division of Endocrinology	11/1/09	1/31/14
Repertoire analysis of T cells in T1D	Jeffrey Bluestone, PhD	Division of Endocrinology	1/1/10	2/28/11
Metabolic Impact of Fructose Restriction in Obese Children	Robert Lustig, MD	Division of Endocrinology	7/1/10	6/30/15
Immune modulation for the treatment of type 1 diabetes	Jeffrey Bluestone, PhD	Division of Endocrinology	7/1/10	6/30/13
Spontaneous Autoimmune Model of Peripheral Neuropathy	Jeffrey Bluestone, PhD	Division of Endocrinology	8/2/10	7/31/11
Tolerance induction using engineered stem cell-specific regulatory T cells	Jeffrey Bluestone, PhD	Division of Endocrinology	12/31/10	12/30/13
CD4+ FoxP3 lineage cells in CNS autoimmune disease and therapy	Jeffrey Bluestone, PhD	Division of Endocrinology	4/1/11	3/31/14
Multiple Approach to Study Type 1 Diabetes with Residual C-Peptide	Jeffrey Bluestone, PhD	Division of Endocrinology	6/1/11	5/31/12
Immunomodulation of transplant rejection by anti-CD3 mAb	Jeffrey Bluestone, PhD	Division of Endocrinology	6/10/11	11/30/16

Global Research Projects